Navigation Links
Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
Date:10/31/2008

SHANGHAI, China, Oct. 31 /Xinhua-PRNewswire/ -- Sundia MediTech Company, a Shanghai-based drug discovery and pharmaceutical development outsourcing service company (CRO) received this year's Deloitte Technology Fast 50 China award, and ranked number 16. The result of Deloitte Technology Fast 50 China Program was announced today in Shenzhen, China at a special ceremony.

Deloitte Technology Fast 50 Program started in 1995 in San Jose. This program quickly expanded to numerous cities and countries. In 2005, Deloitte China launched the "Deloitte Technology Fast 50 China" program. Participants in the Deloitte Technology Fast 50 China program will automatically qualify for participation in the Deloitte Technology Fast 500 Asia Pacific 2008 program, which annually recognises the 500 fastest growing technology companies in Asia Pacific.

Sundia was named consecutively in 2007 and 2008 as one of the top 50 most valuable companies for investment in China. About the Deloitte Technology Fast award, Dr. Xiaochuan Wang, Sundia's CEO said "it is another recognition of Sundia's achievement, and also recognition of China's CRO industry development."

Sudia has kept a high speed for business growth in the 4 and half year history of the company. Last year, Sundia successfully merged with another CRO company United Pharmatech Company in Shanghai. According to Dr. Shi Xiongwei, the founder of United Pharmatech and now Executive VP of Sundia, the company has expanded its business scope from the original chemistry service area to cover most drug discovery and pharmaceutical development areas. The company has made significant contribution to some new drug development programs for clients. Through closely working with client companies, they have successfully advanced a few programs to preclinical or clinical stage.

Sundia's CFO Mr. Beijia Yu and Vice President Dr. Jiong Chen attended today's ceremony to receive "Deloitte Technology Fast 50 China" award.

About the Company

Sundia MediTech Company was founded in Shanghai in 2004 by a group of veterans of the US pharmaceutical industry to provide drug discovery and pharmaceutical development CRO services to clients worldwide. Over the past 4 years, Sundia has built a strong reputation in its field.


'/>"/>
SOURCE Sundia MediTech Company
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. AMICAS Announces Integrations at More Than 100 MEDITECH Facilities
2. Abt Associates Ranked One of Top 20 U.S. Market Research Firms
3. Aldrichimica Acta Ranked First in Organic Chemistry by Impact Factor
4. Alma Lasers Ranked 9th in Deloitte Technology Fast 50 Award
5. Align Technology, Inc. Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific & Medical Equipment, and Bio-Technology Companies
6. WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China
7. CardioDynamics Ranked in Deloittes Technology Fast 50 Program for San Diego
8. AMDL, Inc. Named to Deloitte LLC Technology Fast 50
9. Althea Technologies Receives Fast Growth Honors: Deloitte Technology Fast 50 and San Diego Business Journal Fast 100 Awards for the Fifth Consecutive Year
10. Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Ranks in Deloittes 2008 Washington State Technology Fast 50 for 5th Time in Past 7 Years
11. In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... Parallel 6 , the leading software as a service ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication ... , Using the CONSULT module, patients and physicians can schedule a face to face ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a leader in clinical ... Patient Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits ... tips, tools, and strategies for clinical researchers. , “The landscape of how patients ...
Breaking Biology Technology:
(Date:5/9/2016)... UAE, May 9, 2016 Elevay ... comes to expanding freedom for high net worth professionals ... in today,s globally connected world, there is still no ... could ever duplicate sealing your deal with a firm ... passports by taking advantage of citizenship via investment programs ...
(Date:4/26/2016)... April 27, 2016 Research ... Multi-modal Biometrics Market 2016-2020"  report to their offering.  ... The analysts forecast the global multimodal ... 15.49% during the period 2016-2020.  Multimodal ... sectors such as the healthcare, BFSI, transportation, automotive, ...
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
Breaking Biology News(10 mins):